A two-generation oral gavage reproduction study with potassium perfluorobutanesulfonate (K+PFBS) in Sprague Dawley rats

Toxicology

Volumn 259, Issue 1-2, 2009, Pages 33-45

  Lieder, Paul H ^a   York, Raymond G ^b   Hakes, Daniel C ^a   Chang, Shu Ching ^a   Butenhoff, John L ^a  

^a 3M COMPANY   (United States)

^b RG York and Associates   (United States)

Author keywords

Multi generation; Perfluorobutanesulfonate; PFBS; Reproduction

Indexed keywords

FLUORIDE; PERFLUOROOCTANESULFONYL FLUORIDE; PERFLUOROOCTANOIC ACID; POTASSIUM PERFLUOROBUTANESULFONATE; SURFACTANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; FOOD INTAKE; GESTATION PERIOD; LACTATION; LIVER HYPERTROPHY; LIVER WEIGHT; MALE; MATING; NATURAL CHILDBIRTH; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; SEXUAL MATURATION; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; WEANING;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ESTROUS CYCLE; FEMALE; FERTILITY; FLUOROCARBONS; GENITALIA; LITTER SIZE; MALE; NO-OBSERVED-ADVERSE-EFFECT LEVEL; ORGAN SIZE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCTION; SEXUAL BEHAVIOR, ANIMAL; SULFONIC ACIDS; SURFACE-ACTIVE AGENTS;

RATTUS;

EID: 63149157945     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.01.027     Document Type: Article

References (42)

1. Buist S.C., Cherrington N.J., Choudhuri S., Hartley D.P., and Klaassen C.D. Gender-specific and developmental influences on the expression of rat organic anion transporters. J. Pharmacol. Exp. Ther. 301 (2002) 145-151
2. Buist S.C., Cherrington N.J., and Klaassen C.D. Endocrine regulation of rat organic anion transporters. Drug Metab. Dispos. 31 (2003) 559-564
3. Buist S.C., and Klaassen C.D. Rat and mouse differences in gender-predominant expression of organic anion transporter (Oat1-3; Slc22a6-8) mRNA levels. Drug Metab. Dispos. 32 (2004) 620-625
4. Butenhoff J.L., Kennedy Jr. G.L., Frame S.R., O'Connor J.C., and York R.G. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 196 (2004) 95-116
5. +PFOS) in rats: Developmental neurotoxicity. Reprod. Toxicol., in press, doi:10.1016/j.reprotox.2008.12.010.
6. CanadaGazette, 2004. Canadian Environmental Protection Act, 1999, of the Ministerial Prohibitions. Part I, Subsection 84 (5), 1951-1952.
7. CanadaGazette., 2005. Canadian Environmental Protection Act, 1999, of the Ministerial Prohibitions. Part I, Subsection 84 (5), 266.
8. 2OH: kinetics and mechanism of reaction with OH. Environ. Sci. Technol. 40 (2006) 1862-1868
9. David R.M., Moore M.R., Finney D.C., and Guest D. Chronic toxicity of di(2-ethylhexyl)phthalate in rats. Toxicol. Sci. 55 (2000) 433-443
10. David R.M., Moore M.R., Finney D.C., and Guest D. Reversibility of the chronic effects of di(2-ethylhexyl)phthalate. Toxicol. Pathol. 29 (2001) 430-439
11. Dunn O. Multiple comparisons using rank sums. Technometrics 6 (1964) 241-252
12. Dunnett C. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50 (1955) 1096-1121
13. Frame S.R., Carakostas M.C., and Warheit D.B. Inhalation toxicity of an isomeric mixture of hydrochlorofluorocarbon (HCFC) 225 in male rats. Fundam. Appl. Toxicol. 18 (1992) 590-595
14. Grasty, R.C., Bjork, J.A., Wallace, K.B., Wolf, D.C., Lau, C.S., Rogers, J.M., 2006. Corrigendum: effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat. Birth Defects Res. (Part B) 74, 405-416, 2005. Birth Defects Res. B Dev. Reprod. Toxicol. 77, 87.
15. Hinderliter P.M., Mylchreest E., Gannon S.A., Butenhoff J.L., and Kennedy Jr. G.L. Perfluorooctanoate: placental and lactational transport pharmacokinetics in rats. Toxicology 211 (2005) 139-148
16. Hinderliter P.M., Han X., Kennedy G.L., and Butenhoff J.L. Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO). Toxicology 225 (2006) 195-203
17. ILAR. Guide for the Care and Use of Laboratory Animals (1996), National Research Council, Institute of Laboratory Animal Resources, National Academy Press, Washington, DC
18. Kennedy Jr. G.L., Butenhoff J.L., Olsen G.W., O'Connor J.C., Seacat A.M., Perkins R.G., Biegel L.B., Murphy S.R., and Farrar D.G. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 34 (2004) 351-384
19. Kudo N., Katakura M., Sato Y., and Kawashima Y. Sex hormone-regulated renal transport of perfluorooctanoic acid. Chem. Biol. Interact. 139 (2002) 301-316
20. Kudo N., and Kawashima Y. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J. Toxicol. Sci. 28 (2003) 49-57
21. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., Butenhoff J.L., and Stevenson L.A. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol. Sci. 74 (2003) 382-392
22. Lau C., Butenhoff J.L., and Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 198 (2004) 231-241
23. Lau C., Thibodeaux J.R., Hanson R.G., Narotsky M.G., Rogers J.M., Lindstrom A.B., and Strynar M.J. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol. Sci. 90 (2006) 510-518
24. Lewis E.M., Barnett Jr. J.F., Freshwater L., Hoberman A.M., and Christian M.S. Sexual maturation data for Crl Sprague-Dawley rats: criteria and confounding factors. Drug Chem. Toxicol. 25 (2002) 437-458
25. Lieder P.H., Chang S.C., York R.G., and Butenhoff J.L. Toxicological evaluation of potassium perfluorobutanesulfonate in a 90-day oral gavage study with Sprague Dawley rats. Toxicology 255 (2009) 45-52
26. Luebker D.J., Case M.T., York R.G., Moore J.A., Hansen K.J., and Butenhoff J.L. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 215 (2005) 126-148
27. Luebker D.J., York R.G., Hansen K.J., Moore J.A., and Butenhoff J.L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 215 (2005) 149-169
28. Marsman, D., 1995. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Toxic. Rep. Ser. 30, 1-G5.
29. NICNAS, 2005. Existing Chemicals Hazard Assessment Report: Potassium Perfluorobutane Sulfonate. National Industrial Chemicals Notification and Assessment Scheme, Australian Government Department of Health and Aging.
30. Olsen G.W., Chang S.C., Noker P.E., Gorman G.S., Ehresman D.J., Lieder P.H., and Butenhoff J.L. A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans. Toxicology 256 (2009) 65-74
31. Siegel S. Nonparametric Statistics for the Behavioral Sciences (1956), McGraw-Hill, New York
32. Snedecor G., and Cochron W. Variance Test for Homogeneity of the Binomial Distribution (1967), Iowa State University Press, Ames
33. Snedecor G.W., and Cochran W.G. Analysis of variance. Statistical Methods (1967), Iowa State University Press, Ames pp. 258-275
34. Sokal R.R., and Rohlf F.J. Bartlett's test of homogeneity of variances. Biometry (1969), W.H. Freeman and Company pp. 370-371
35. Sokol R., and Rohlf F. Kruskal-Wallis test. Biometry (1969), W.H. Freeman and Company, San Francisco pp. 388-389
36. Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., Richards J.H., butenhoff J.L., Stevenson L.A., and Lau C. Exposure to perfluorooctane sulfonate during pregnancy in rats and mouse. I. Maternal and prenatal evaluations. Toxicol. Sci. 74 (2003) 369-391
37. Toyosawa K., Okimoto K., Kobayashi I., Kijima K., Kikawa E., Kohchi M., Koujitani T., Tanaka K., and Matsuoka N. Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study. Toxicol. Pathol. 29 (2001) 458-466
38. USEPA, 2002. Rules and regulations. United States Federal Register 67, 72854-72867.
39. USEPA, 2006. Proposed rules. United States Federal Register 71, 12311-12324.
40. Wolf C.J., Takacs M.L., Schmid J.E., Lau C., and Abbott B.D. Activation of mouse and human peroxisome proliferator-activated receptor alpha (PPARα) by perfluoroalkyl acids (PFAAs) of different functional groups and chain lengths. Toxicol. Sci. 106 (2008) 162-171
41. Xu L., Krenitsky D.M., Seacat A.M., Butenhoff J.L., and Anders M.W. Biotransformation of N-ethyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450. Chem. Res. Toxicol. 17 (2004) 767-775
42. Xu L., Krenitsky D.M., Seacat A.M., Butenhoff J.L., Tephly T.R., and Anders M.W. N-glucuronidation of perfluorooctanesulfonamide by human, rat, dog, and monkey liver microsomes and by expressed rat and human UDP-glucuronosyltransferases. Drug Metab. Dispos. 34 (2006) 1406-1410